Related Articles
Impact of positive ZEB1 expression in patients with epithelial ovarian carcinoma as an oncologic outcome‑predicting indicator
Management of bilateral malignant ovarian germ cell tumors: Experience of a single institute
Hematopoietic lineage cell‑specific protein 1 immunoreactivity indicates an increased risk of poor overall survival in patients with ovarian carcinoma
Borderline epithelial tumors of the ovary: Experience of 55 patients
<em>Ex vivo</em> assessment of cancer drug sensitivity in epithelial ovarian cancer and its association with histopathological type, treatment history and clinical outcome